Invivyd (IVVD) Gross Profit (2024 - 2026)
Invivyd's (IVVD) quarterly Gross Profit came in at $16.1 million in Q4 2025, up 22.69% YoY from $13.1 million in Q4 2024, and up 33.44% on a QoQ basis from $12.0 million in Q3 2025.
Invivyd (IVVD) Gross Profit (2024 - 2026) Analysis & Trends
Invivyd (IVVD) has 2 years of Gross Profit data on file, last reported at $16.1 million in Q4 2025.
- Quarterly Gross Profit rose 22.69% year-over-year to $16.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $49.7 million (up 109.03% YoY) and the FY2025 annual result came in at $49.7 million, up 109.03% from the prior year.
- Gross Profit advanced to $16.1 million in Q4 2025, from $12.0 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $16.1 million in Q4 2025 to a low of $2.2 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Invivyd | 212.23 Mn | 52.15 Mn | 13.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.01 Mn |
| Jun 30, 2026 | 13.01 Mn |
| Dec 31, 2025 | 16.07 Mn |
| Dec 31, 2025 | 16.07 Mn |
| Sep 30, 2025 | 12.04 Mn |
| Sep 30, 2025 | 12.04 Mn |
| Jun 30, 2025 | 11.10 Mn |
| Jun 30, 2025 | 11.10 Mn |
| Mar 31, 2025 | 10.47 Mn |
| Mar 31, 2025 | 10.47 Mn |
| Dec 31, 2024 | 13.10 Mn |
| Dec 31, 2024 | 13.10 Mn |
| Sep 30, 2024 | 8.49 Mn |
| Sep 30, 2024 | 8.49 Mn |
| Jun 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 2.18 Mn |